Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

Purpose: To assess the safety and feasibility of intravitreal injection of autologous CD34+ bone marrow stem cells (BMSCs) in eyes with vision loss from central retinal vein occlusion (CRVO). Design: Phase I/II single-center, prospective, randomized, sham-controlled, double-masked study. Participant...

Full description

Bibliographic Details

Published in:	Ophthalmology Science
Main Authors:	Susanna S. Park, MD, PhD, Jennifer McCormack, MS, Dagmar Salazar, MS, Jacquie S. King, MS, Marisa Salvador, BA, Gerhard Bauer, BS, Brian Fury, MS, Mehrdad Abedi, MD, Ala Moshiri, MD, PhD, Denise Macias, BS, Kareem Moussa, MD, Radhika Kondapaka, MBBS, Robert Lindblad, MD, Rasmus Hoeg, MD, Jan A. Nolta, PhD
Format:	Article
Language:	English
Published:	Elsevier 2026-01-01
Subjects:	Autologous stem cells Bone marrow stem cells CD34+ cells Intravitreal cell injection Retinal vein occlusion
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666914525002039